[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100530123":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":40,"responsibleParty":55,"collaborators":26,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":60,"sex":66,"minAge":67,"maxAge":26,"enrollmentInfo":68,"targetDuration":26,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":79,"overallStatus":42,"whyStopped":26,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Korea University Guro Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Angiography-guided PCI group","ACTIVE_COMPARATOR","This group of patients are intended to undergo PCI with conventional angiography-guidance. Procedural optimization determined by angiographic assessment.",[13],"Diagnostic Test: Coronary angiography",{"label":15,"type":16,"description":17,"interventionNames":18},"Concurrent OCT\u002FFFR-guided PCI group","EXPERIMENTAL","This group of patients are intended to undergo PCI with concurrent OCT\u002FFFR-guidance. Procedural optimization determined by OCT and FFR assessment.",[19,13],"Diagnostic Test: optical coherence tomography and fractional flow reserve",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DIAGNOSTIC_TEST","optical coherence tomography and fractional flow reserve","The assessment of pre-procedural lesions and optimization status of implanted stents will involve both intracoronary imaging and physiological indices.",[15],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Coronary angiography","The assessment of pre-procedural lesions and optimization status of implanted stents will be determined by conventional coronary angiography",[9,15],[32],{"name":33,"affiliation":5,"role":34},"Dong Oh Kang, MD, PhD","PRINCIPAL_INVESTIGATOR",[36],{"name":33,"role":37,"phone":38,"phoneExt":26,"email":39},"CONTACT","82-2-2626-3184","gelly9@naver.com",[41],{"facility":5,"status":42,"city":43,"state":26,"zip":44,"country":45,"countryCode":26,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"RECRUITING","Seoul","08308","South Korea",{"type":47,"coordinates":48},"Point",[49,50],126.9784,37.566,{"lat":50,"lon":49},[53],{"name":33,"role":37,"phone":54,"phoneExt":26,"email":39},"+82-2-2626-3184",{"type":34,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Kang Dong Oh","Assistant Professor","100530123","concurrent-oct-and-ffr-guided-pci-in-cad-100530123",false,"NCT06182683","Concurrent OCT and FFR-guided PCI in CAD","Concurrent OPTIcal Coherence Tomography and frActional Flow REserve-guided Therapeutic Intervention in Patients With Coronary Artery Disease (OPTICARE-CAD)","OPTICARE-CAD","Inclusion Criteria:\n\n1. Age greater than 19 years old\n2. Patients undergoing coronary stent implantation for stable angina or acute coronary syndrome\n3. Patients provided on informed consent\n\nExclusion Criteria:\n\n1. Individuals with a history of increased bleeding tendencies or hematologic disorders\n2. Presented with refractory cardiogenic shock\n3. Individuals with a history of stent thrombosis\n4. Expected life expectancy of less than 1 year\n5. Left ventricular ejection fraction (LVEF) ≥ 20%\n6. Women who are breastfeeding, pregnant, or planning to become pregnant\n7. Deemed unsuitable for participation by the investigator\n8. Patients unwilling to participate in the clinical trial","ALL","19 Years",{"count":69,"type":70},700,"ESTIMATED","INTERVENTIONAL",[73],"NA","The present study is a prospective randomized clinical trial aimed to compare the therapeutic strategy of angiography-guided versus concurrent OCT\u002FFFR-guided intervention in patients with coronary artery disease.",[76,77,78],"Coronary Artery Disease","Image","Atheroscleroses, Coronary",[80,81,82,83,84,85],"Optical coherence tomography","Fractional flow reserve","Angiography","Coronary artery disease","Percutaneous coronary intervention","Drug-eluting stent","2023-12-25",{"date":88,"type":89},"2023-12-27","ACTUAL",{"date":91,"type":89},"2023-11-30",{"date":93,"type":70},"2029-12-31",{"name":5,"class":6},1]